Antiproliferative and apoptotic activity of gemcitabine-lauric acid conjugate on human bladder cancer cells

OBJECTIVE(S): Gemcitabine is a first-line drug for the treatment of bladder cancer. One of the most important mechanisms of gemcitabine resistance is the low expression of cellular membrane transporter hENT1. Various derivatives containing fatty acid side chains have been developed in order to facil...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hongxia, Shao, Zhiyu, Xu, Zhiwen, Ye, Binghao, Li, Ming, Zheng, Qiaoqiao, Ma, Xingyuan, Shi, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mashhad University of Medical Sciences 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9150810/
https://www.ncbi.nlm.nih.gov/pubmed/35656081
http://dx.doi.org/10.22038/IJBMS.2022.61118.13528

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9150810/
https://www.ncbi.nlm.nih.gov/pubmed/35656081
http://dx.doi.org/10.22038/IJBMS.2022.61118.13528

Ejemplares similares